Yazdan Yazdanpanah - Concepedia

Author

Yazdan Yazdanpanah

Also Known As

A Barrail-Tran, A Hoang, A Rami, Andrea Antinori, Anne-Marie Taburet, Baron, S., Benoit Visseaux, C Rioux, CEPAC-International Investigators, Christelle Tual

737

Publications

35.8K

Citations

H-Index

193

Concepts

All Affiliations

Inserm Université Paris Cité Hôpital Bichat-Claude-Bernard Assistance Publique – Hôpitaux de Paris Université Claude Bernard Lyon 1

About

Yazdan Yazdanpanah is an author at Inserm specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	93	6.1K
2	Public Health	23	38	3.4K
3	Health Sciences	5	5	160
4	Nursing	3	3	221
5	Social Sciences	2	2	50

Yazdan Yazdanpanah

248

Publications

20.2K

Citations

H-Index

Page 1

	Year	Citations
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients Nisreen M.A. Okba, Marcel A. Müller, Wentao Li, Emerging infectious diseases	2020	1.7K
Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study Marius Gilbert, Giulia Pullano, Francesco Pinotti, The Lancet Virus EpidemiologyGlobal HealthGlobal Health CrisisCovid-19 PandemicInternational Health	2020	1.3K
Clinical and virological data of the first cases of COVID-19 in Europe: a case series François-Xavier Lescure, Lila Bouadma, Duc Nguyen, The Lancet Infectious Diseases	2020	1.2K
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Jean‐François Rahier, Fernando Magro, Cândida Abreu, Journal of Crohn s and Colitis	2014	909
Type 1 interferons as a potential treatment against COVID-19 Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah, Antiviral Research Covid-19 PandemicImmunologyAntiviral TherapyVirologyMedicine	2020	549
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial David A. Margolis, Juan González‐García, Hans-Jürgen Stellbrink, The Lancet Treatment And PreventionMedicinePhase 2BLong-acting Intramuscular CabotegravirAntiviral Therapy	2017	492
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea Daouda Sissoko, Cédric Laouenan, Elin Folkesson, PLoS Medicine	2016	477
Culture of Percutaneous Bone Biopsy Specimens For Diagnosis of Diabetic Foot Osteomyelitis: Concordance With Ulcer Swab Cultures Éric Senneville, Hugues Melliez, E. Beltrand, Clinical Infectious Diseases	2005	315
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists Lila Bouadma, François-Xavier Lescure, Jean-Christophe Lucet, Intensive Care Medicine Severe Sars-cov-2 InfectionsCovid-19 PandemicHealthcare-associated InfectionVirologyEmerging Infectious Disease	2020	312
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot, The Lancet Respiratory Medicine	2021	293

Page 1